Lozano-Sepúlveda SA, Rincón-Sanchez AR, Rivas-Estilla AM. Antioxidants benefits in hepatitis C infection in the new
DAAs era.
Ann Hepatol 2020;
18:410-415. [PMID:
31122787 DOI:
10.1016/j.aohep.2019.04.004]
[Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Accepted: 02/25/2019] [Indexed: 02/04/2023]
Abstract
Some of the evidence on whether antioxidant supplements are effective in treatment of liver diseases is contradictory. Here we perform a descriptive analysis of the available data in vivo and in vitro of the possible antiviral action and controversy of several antioxidant molecules against HCV.
Collapse